Kim Kamdar

Dr. Kamdar is a Partner with Domain Associates, a healthcare venture capital leader. With a background in small molecule drug discovery, she has been involved in cutting-edge therapeutic start-ups and has been a major part of identifying companies with promising molecular and companion diagnostics to support personalized medicine. Dr. Kamdar is currently Chair of the Board of Directors of Obalon Therapeutics and serves on the boards of Epic Sciences, Evofem Biosciences, Omniome and Sera Prognostics. She is also a board member of San Diego’s CONNECT Foundation and an advisory board member of Eric Topol’s NIH-supported Clinical and Translational Science Award for Scripps Medicine.

Dr. Kamdar is the author of 10 papers as well as the inventor on seven patents. She received her B.A. from Northwestern University and her Ph.D. in Biochemistry and Genetics from Emory University.